Dr. Gary Levy

BSc, MD, ARLAT, FRCPC
Professor, Departments of Medicine, Immunology, and Surgery, University of Toronto

TRP Role: 

Transplant Translator Professor

Research Interests:

Prof. Levy’s research has focused on the immune-mediated mechanisms of organ injury due to viruses, alloantigens and xenoantigens. His  research and clinical focus presently is  on finding a way to achieve immunological tolerance, which could allow patients who have undergone solid organ transplant to discontinue their long term need for immunosuppression. He has published over 400 peer-reviewed articles, books and book chapters, and has trained over 60 masters and PhD students.

Brief Bio:

Dr. Levy has made an outstanding contribution to the study of liver disease. He is currently seeking a way to achieve immunological tolerance that could allow patients who have undergone solid organ transplant to discontinue their long-term immunosuppression therapy. He was an elected member of the American Society for Clinical Investigation in 1988. He received the Canadian Liver Foundation Commemorative Medal for the Queen’s Jubilee, the Dr Richard Hunt Outstanding Service Award from the Canadian Digestive Health Foundation, the Dean’s Lifetime Achievement Award from the Institute of Medical Science, and many other awards. In 2015, he was appointed to the Order of Ontario.

Dr. Levy is also a leading educator. He has trained over 60 MSc and PhD students. He is a professor in the Departments of Medicine, Immunology, and Surgery at U of T and an honorary professor at Tongji University in China. He co-founded and directed the Multi Organ Transplant Program at the University Health Network and the U of T Transplantation Institute.